Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy

NCT03912766 is registered in ClinicalTrials.gov with Medical University of Lodz as lead sponsor.

NCT NCT03912766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03912766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Copeptin as a Predictor of the Risk of Hyponatremia After Transurethral Prostatectomy
Lead sponsor
Medical University of Lodz
Phase
Observational
Overall status
Completed
Start date
February 1, 2016
Completion date
March 30, 2018
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign prostatic hyperplasia